Pierre‐François Laterre

机构：Cliniques Universitaires Saint-Luc · ORCID：0000-0001-5712-7449

发表论文 648 篇 · 总被引 22645 次 · h-index 72

代表论文

• Prospective evaluation of the efficacy, safety, and optimal biomarker enrichment strategy for nangibotide, a TREM-1 inhibitor, in patients with septic shock (ASTONISH): a double-blind, randomised, controlled, phase 2b trial (2023 · The Lancet Respiratory Medicine · 被引 76)
• Convalescent Plasma for Covid-19–Induced ARDS in Mechanically Ventilated Patients (2023 · New England Journal of Medicine · 被引 72)
• Preoperative frailty screening, assessment and management (2022 · Current Opinion in Anaesthesiology · 被引 56)
• Thoracic epidural analgesia in intensive care unit patients with acute pancreatitis: the EPIPAN multicenter randomized controlled trial (2023 · Critical Care · 被引 25)
• Circulating dipeptidyl peptidase 3 and bio-adrenomedullin levels are associated with impaired outcomes in critically ill COVID-19 patients: a prospective international multicentre study (2022 · ERJ Open Research · 被引 25)
• Effects of enrichment strategies on outcome of adrecizumab treatment in septic shock: Post-hoc analyses of the phase II adrenomedullin and outcome in septic shock 2 trial (2022 · Frontiers in Medicine · 被引 22)